The sale is small relative to market cap and follows a pattern of monthly option-exercise-and-sell transactions by this insider. No material signal for the stock; monitor for any change in the cadence or size of insider sales.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $234.11entry
- T+1 · 6d ago +1.89%α +0.57% · $238.53
- T+4 · todayOpen
- T+5 · in 8h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Michael J. Farrell, an officer and director of ResMed, filed a Form 144 notice of intent to sell 4,993 shares of common stock with an approximate market value of $1.175 million. The shares were acquired through a stock option exercise on the same day, and the sale is planned for execution on the NYSE.
Key Facts
- Michael J. Farrell (Officer and Director) filed Form 144 to sell 4,993 shares
- Estimated aggregate market value of the proposed sale: $1,175,089.20
- Shares were acquired via stock option exercise on 11/09/2026
- Proposed sale date: 11/09/2026
- Broker: Fidelity Brokerage Services LLC
- Farrell's most recent prior sales: 4,991 shares on 09/08/2026 and 4,991 shares on 10/07/2026
Financial Impact
Proposed sale of 4,993 shares valued at approximately $1.175 million, representing about 0.0035% of ResMed's $33.7B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- Insider selling pattern is routine and does not indicate a change in outlook
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007872 |
| Document: 0001959173-26-007872-index.html | 0001959173-26-007872 |
| Document: 0001959173-26-007872.txt | 0001959173-26-007872 |
Track record
19 reports on RMD
4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $234.11 Now $238.19 +1.74% settles Dec 9
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
- Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
- Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
- Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
- Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers